NTRA
Natera, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$262.63-3.23%
Price as of Jul 20, 2026
NTRA profitability
Natera, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 65.2%
- EBITDA margin
- -8.9%
- EBIT margin
- -13.0%
- Net margin
- -9.0%
- Free cash flow margin
- 3.7%
Returns
- Return on equity
- -12.8%
- Return on assets
- -8.7%
- Return on invested capital
- -16.1%
- Asset turnover
- 0.98x
Cash efficiency
- Cash from operations
- $211.0M
- Cash per share
- $7.60
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.